Hege Kersten

952 total citations
32 papers, 641 citations indexed

About

Hege Kersten is a scholar working on Psychiatry and Mental health, Geriatrics and Gerontology and Economics and Econometrics. According to data from OpenAlex, Hege Kersten has authored 32 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 11 papers in Geriatrics and Gerontology and 9 papers in Economics and Econometrics. Recurrent topics in Hege Kersten's work include Dementia and Cognitive Impairment Research (9 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Pharmaceutical Practices and Patient Outcomes (9 papers). Hege Kersten is often cited by papers focused on Dementia and Cognitive Impairment Research (9 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Pharmaceutical Practices and Patient Outcomes (9 papers). Hege Kersten collaborates with scholars based in Norway, United Kingdom and United States. Hege Kersten's co-authors include Torgeir Bruun Wyller, Espen Molden, Knut Engedal, Eva Skovlund, Geir Selbæk, Jørund Straand, Kaisu Pitkälä, Tiril Willumsen, Jūratė Šaltytė Benth and Anne‐Brita Knapskog and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of the American Geriatrics Society.

In The Last Decade

Hege Kersten

31 papers receiving 620 citations

Peers

Hege Kersten
Hege Kersten
Citations per year, relative to Hege Kersten Hege Kersten (= 1×) peers Paola Danese

Countries citing papers authored by Hege Kersten

Since Specialization
Citations

This map shows the geographic impact of Hege Kersten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hege Kersten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hege Kersten more than expected).

Fields of papers citing papers by Hege Kersten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hege Kersten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hege Kersten. The network helps show where Hege Kersten may publish in the future.

Co-authorship network of co-authors of Hege Kersten

This figure shows the co-authorship network connecting the top 25 collaborators of Hege Kersten. A scholar is included among the top collaborators of Hege Kersten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hege Kersten. Hege Kersten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tveten, Yngvar, Hege Kersten, Harald Reiso, et al.. (2025). SARS-CoV-2-specific humoral immunity in a Norwegian cohort between 2020 and 2023. BMC Medicine. 23(1). 332–332.
2.
Skudal, Hilde, Åslaug Rudjord Lorentzen, Tore Stenstad, et al.. (2024). Clinical characteristics and factors affecting disease severity in hospitalized tick-borne encephalitis patients in Norway from 2018 to 2022. European Journal of Clinical Microbiology & Infectious Diseases. 43(7). 1355–1366. 4 indexed citations
3.
Zhang, Chi, Yngvar Tveten, Hege Kersten, et al.. (2024). Risk factors for SARS-CoV-2 infection: a test-negative case–control study with additional population controls in Norway. BMJ Open. 14(1). e073766–e073766. 1 indexed citations
4.
Kersten, Hege, et al.. (2022). The association between geriatric treatment and 30-day readmission risk among medical inpatients aged ≥75 years with multimorbidity. PLoS ONE. 17(1). e0262340–e0262340. 2 indexed citations
5.
Diep, Lien My, Chi Zhang, Yngvar Tveten, et al.. (2022). SARS-CoV-2 antibody persistence after five and twelve months: A cohort study from South-Eastern Norway. PLoS ONE. 17(8). e0264667–e0264667. 8 indexed citations
6.
Flemmen, Heidi Øyen, Cecilia Smith Simonsen, Line Broch, et al.. (2022). The influence of socioeconomic factors on access to disease modifying treatment in a Norwegian multiple sclerosis cohort. Multiple Sclerosis and Related Disorders. 61. 103759–103759. 5 indexed citations
7.
Flemmen, Heidi Øyen, Cecilia Smith Simonsen, Line Broch, et al.. (2021). Maternal education has significant influence on progression in multiple sclerosis. Multiple Sclerosis and Related Disorders. 53. 103052–103052. 8 indexed citations
8.
Myklebust, Tor Åge, et al.. (2021). Fear of Recurrence in Prostate Cancer Patients: A Cross-sectional Study After Radical Prostatectomy or Active Surveillance. European Urology Open Science. 25. 44–51. 13 indexed citations
9.
Watne, Leiv Otto, et al.. (2021). Association between psychotropic drug use and handgrip strength in older hospitalized patients. European Geriatric Medicine. 12(6). 1213–1220. 9 indexed citations
10.
Flemmen, Heidi Øyen, Cecilia Smith Simonsen, Pål Berg‐Hansen, et al.. (2020). Prevalence of multiple sclerosis in rural and urban districts in Telemark county, Norway. Multiple Sclerosis and Related Disorders. 45. 102352–102352. 13 indexed citations
11.
12.
Wyller, Torgeir Bruun, et al.. (2019). Can screening tools for potentially inappropriate prescriptions in older adults prevent serious adverse drug events?. European Journal of Clinical Pharmacology. 75(5). 627–637. 18 indexed citations
13.
Engedal, Knut, et al.. (2018). Quality of Life in People with Young-Onset Alzheimer’s Dementia and Frontotemporal Dementia. Dementia and Geriatric Cognitive Disorders. 45(1-2). 91–104. 18 indexed citations
15.
Barca, Maria Lage, Karin Persson, Rannveig Sakshaug Eldholm, et al.. (2017). Trajectories of depressive symptoms and their relationship to the progression of dementia. Journal of Affective Disorders. 222. 146–152. 40 indexed citations
16.
Kersten, Hege, et al.. (2014). Brief Tests such as the Clock Drawing Test or Cognistat Can Be Useful Predictors of Conversion from MCI to Dementia in the Clinical Assessment of Outpatients. Dementia and Geriatric Cognitive Disorders Extra. 4(2). 263–270. 10 indexed citations
17.
Kersten, Hege, Torgeir Bruun Wyller, & Espen Molden. (2013). Association Between Inherited CYP2D6/2C19 Phenotypes and Anticholinergic Measures in Elderly Patients Using Anticholinergic Drugs. Therapeutic Drug Monitoring. 36(1). 125–130. 8 indexed citations
18.
Kersten, Hege, et al.. (2012). Cognitive Effects of Reducing Anticholinergic Drug Burden in a Frail Elderly Population: A Randomized Controlled Trial. The Journals of Gerontology Series A. 68(3). 271–278. 98 indexed citations
19.
Kersten, Hege, et al.. (2011). Evaluation of Brain Anticholinergic Activities of Urinary Spasmolytic Drugs Using a High‐Throughput Radio Receptor Bioassay. Journal of the American Geriatrics Society. 59(3). 501–505. 19 indexed citations
20.
Kersten, Hege, Sabine Ruths, & Torgeir Bruun Wyller. (2009). Farmakoterapi i sykehjem. Tidsskrift for Den norske legeforening. 129(17). 1732–1735. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026